ScholarGate
Pembantu

Gestational Diabetes Mellitus

Gestational diabetes mellitus is hyperglycaemia first recognized during pregnancy in a woman not previously known to have diabetes. It reflects the increased insulin resistance of pregnancy combined with limited beta-cell reserve, and it carries risks for both the pregnancy and the longer-term health of mother and child.

Cari Topik dengan PaperMindTidak lama lagiFind papers & topics
Tools & resources
Muat turun slaid
Learn & explore
VideoTidak lama lagi

Definition

Gestational diabetes mellitus is diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes before gestation, arising when pregnancy-related insulin resistance outstrips the capacity to secrete enough insulin.

Scope

This topic covers the physiology of glucose handling in pregnancy, the definition and diagnostic basis of gestational diabetes, and its associations with pregnancy outcomes and future diabetes risk. It is framed as a reference clinical entity for understanding mechanism and classification, not as a source of screening protocols or treatment advice.

Core questions

  • Why does pregnancy increase the risk of hyperglycaemia?
  • How is gestational diabetes defined and distinguished from pre-existing diabetes?
  • What pregnancy outcomes are associated with maternal hyperglycaemia?
  • What does a history of gestational diabetes mean for future diabetes risk?

Key concepts

  • Pregnancy-induced insulin resistance
  • Limited beta-cell reserve
  • Continuous glucose–outcome relationship
  • Macrosomia and adverse pregnancy outcomes
  • Diagnostic thresholds in pregnancy
  • Future risk of type 2 diabetes

Mechanisms

Pregnancy is normally a state of progressive insulin resistance, driven by placental hormones, that increases the demand on maternal beta cells to secrete more insulin. Gestational diabetes emerges when beta-cell capacity cannot meet this demand, producing maternal hyperglycaemia. The HAPO study showed that the relationship between maternal glucose and adverse pregnancy outcomes — such as excess fetal growth — is continuous, without a clear threshold, which informed the diagnostic criteria proposed by the IADPSG consensus. Because the underlying insulin resistance often reflects a predisposition that persists, affected women carry an elevated long-term risk of type 2 diabetes.

Clinical relevance

Gestational diabetes is a common pregnancy complication linked to outcomes for both mother and infant and a marker of future maternal diabetes risk, making it important in both obstetric and metabolic care. This entry describes mechanism, classification, and associated risks for reference; it does not provide screening schedules, diagnostic thresholds, or treatment recommendations for individuals.

Epidemiology

Gestational diabetes is among the most common metabolic disorders of pregnancy, with prevalence varying widely by population and by the diagnostic criteria applied. Women with a history of gestational diabetes have a substantially increased risk of developing type 2 diabetes in later life.

Evidence & guidelines

The HAPO study demonstrated a continuous association between maternal glucose levels and adverse pregnancy outcomes, and the IADPSG consensus translated those findings into recommended diagnostic criteria for hyperglycaemia in pregnancy. Classification within the broader diabetes framework is maintained in professional Standards of Care.

History

Gestational diabetes was recognized as a distinct category of glucose intolerance arising in pregnancy. The landmark HAPO study (2008) clarified the continuous glucose–outcome relationship, and the subsequent IADPSG consensus (2010) provided influential, evidence-derived diagnostic criteria that shaped contemporary classification.

Debates

Which diagnostic criteria and screening approach should be used?
Because the glucose–outcome relationship is continuous rather than threshold-based, the choice of diagnostic cut-points and one-step versus two-step screening strategies remains contested, with different bodies adopting different criteria and substantially affecting measured prevalence.

Related topics

Seminal works

  • hapo-2008
  • iadpsg-2010

Frequently asked questions

What is gestational diabetes?
It is hyperglycaemia first recognized during pregnancy in a woman not previously known to have diabetes, arising when pregnancy-related insulin resistance exceeds the capacity to secrete enough insulin.
Does gestational diabetes increase future diabetes risk?
Yes; a history of gestational diabetes is associated with a substantially higher long-term risk of developing type 2 diabetes, reflecting an underlying predisposition to insulin resistance.

Methods for this concept

Related concepts